The Biomedical Advanced Research & Development Authority (BARDA) – part of the US Department of Health – has awarded a $112 million contract to Israel’s Mediwound. BARDA will use Mediwound’s NexoBrid product in major incidents, to remove dead tissues from medium to severe burns. It will also help Mediwound finance its FDA approval for NexoBrid.

http://jewishbusinessnews.com/2015/09/30/israels-mediwound-signs-112-million-deal-in-u-s-for-burn-treatment/